Dashboard
1
High Management Efficiency with a high ROCE of 33.03%
2
High Debt Company with a Debt to Equity ratio (avg) at times
3
Healthy long term growth as Net Sales has grown by an annual rate of 36.93%
4
The company has declared Positive results for the last 4 consecutive quarters
5
With ROE of 43.10%, it has a Expensive valuation with a 12.29 Price to Book Value
6
Market Beating performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
356.25%
0%
356.25%
6 Months
436.76%
0%
436.76%
1 Year
942.86%
0%
942.86%
2 Years
693.48%
0%
693.48%
3 Years
1180.7%
0%
1180.7%
4 Years
1771.79%
0%
1771.79%
5 Years
1116.67%
0%
1116.67%
Fameglow Holdings Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
36.93%
EBIT Growth (5y)
30.40%
EBIT to Interest (avg)
3.78
Debt to EBITDA (avg)
0.28
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
3.21
Tax Ratio
16.86%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
33.03%
ROE (avg)
36.57%
Valuation key factors
Factor
Value
P/E Ratio
29
Industry P/E
Price to Book Value
12.29
EV to EBIT
24.31
EV to EBITDA
11.54
EV to Capital Employed
11.45
EV to Sales
3.02
PEG Ratio
2.25
Dividend Yield
NA
ROCE (Latest)
47.10%
ROE (Latest)
43.10%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bearish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Mar'23
Mar'23
Mar'22
Change(%)
Net Sales
227.60
179.60
26.73%
Operating Profit (PBDIT) excl Other Income
64.30
34.80
84.77%
Interest
3.80
4.90
-22.45%
Exceptional Items
2.00
3.30
-39.39%
Consolidate Net Profit
16.40
-8.80
286.36%
Operating Profit Margin (Excl OI)
76.80%
-46.80%
12.36%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2023 is 26.73% vs 118.76% in Mar 2022
Consolidated Net Profit
YoY Growth in year ended Mar 2023 is 286.36% vs 67.41% in Mar 2022
About Fameglow Holdings Ltd. 
Fameglow Holdings Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






